Kandy Therapeutics Limited (reg no 10753028) is a private limited company created on 2017-05-03 in England. This business is registered at 400 South Oak Way, Reading RG2 6AD. Kandy Therapeutics Limited operates Standard Industrial Classification code: 72110 that means "research and experimental development on biotechnology".

Company details

Name Kandy Therapeutics Limited
Number 10753028
Date of Incorporation: 2017-05-03
End of financial year: 31 December
Address: 400 South Oak Way, Reading, RG2 6AD
SIC code: 72110 - Research and experimental development on biotechnology

As for the 2 directors that can be found in the enterprise, we can name: Ramon P. (appointed on 22 September 2021), Vinit J. (appointment date: 25 August 2021). 1 secretary is also present: Colin B. (appointed on 08 September 2020). The Companies House indexes 3 persons of significant control, namely: Bayer Global Investments Bv can be found at Energieweg,, 3641 Rt Mijdrecht,. This corporate PSC has over 3/4 of shares, 3/4 to full of voting rights. Advent Life Sciences Llp can be found at North Gower Street, NW1 2ND London. This corporate PSC has 1/2 or less of shares, 1/2 or less of voting rights. Michael T. has over 3/4 of shares, 3/4 to full of voting rights.

Directors

People with significant control

Bayer Global Investments Bv
8 September 2020
Address 1 Energieweg,, 3641 Rt Mijdrecht,, Netherlands
Legal authority Burgerlijk Wetboek (Dutch Commercial Law)
Legal form Unlisted Private Company, Limited By Shares
Country registered Netherlands
Place registered Kamer Van Koophandel (The Dutch Commercial Register)
Registration number 51490986
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors
Advent Life Sciences Llp
14 September 2017 - 24 August 2018
Address 158-160 North Gower Street, London, NW1 2ND, England
Legal authority Limited Liabilities Partnership Act 2000
Legal form Limited Liability Partnership
Country registered England
Place registered England
Registration number Oc347034
Nature of control: 25-50% voting rights
25-50% shares
Michael T.
3 May 2017 - 14 September 2017
Nature of control: 75,01-100% shares
75,01-100% voting rights
right to appoint and remove directors

Filings

Categories:
Accounts Address Capital Confirmation statement Incorporation Insolvency Officers Persons with significant control Resolution
(AA) Full accounts for the period ending 2022/12/31
filed on: 30th, June 2023 | accounts
Free Download (24 pages)